Navigation Links
ULURU Inc. Announces Voting Results of Reconvened Annual Meeting of Stockholders
Date:6/17/2011

ADDISON, Texas, June 17, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) today announced that its Annual Meeting of Stockholders was reconvened on June 16, 2011 for the purpose of determining stockholder voting with respect to Proposal No. 3, a proposal to authorize the Board of Directors to amend the Company's Restated Articles of Incorporation at any time prior to July 31, 2011 to effect a reverse stock split of the Company's outstanding common stock at a ratio to be determined by the Board of Directors but not to exceed 15 pre-reverse-split shares into one post-reverse-split share.

As of April 4, 2011, the record date, 87,341,709 shares of common stock were eligible to vote. As of June 16, 2011, approximately 69%, or 60.4 million shares of the Company's outstanding shares have been voted on the charter amendment, and of these shares 46.5 million shares have been voted in favor of the proposal which is in excess of the votes necessary to approve the proposal. The results of the stockholder votes on the third proposal which was considered and voted upon at the reconvened Annual Meeting will be released in a separate 8-K filing.

Kerry P. Gray, the Chairman, Chief Executive Officer and President of ULURU Inc., stated, "We are pleased that our stockholders have voted in favor of this proposal as I believe that implementing the reverse stock split more favorably positions the Company in the financial markets."

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. For further information about ULURU Inc., please visit our website at www.uluruinc.com. For further information about A
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. ULURU Inc. Reports Third Quarter 2010 Financial Results
10. ULURU Inc. to Raise $500,000 in Registered Direct Offering
11. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/11/2014)... Neurelis, Inc. ("Neurelis") today announced an agreement ... held by Biotie to purchase Neurelis, clearing the way ... diazepam) for pediatric and adult epilepsy patients who experience ... Biotie has advanced the development program for NRL-1 and ... work required for NDA submission to the FDA.  Given ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... ... ... var shortURL = ""; BitlyCB.alertResponse = ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key ...
... biotechnology specialist Azantis, Inc . has made a ... an effort to provide continued high quality service to ... SafetyCall International , Azantis has partnered with the recognized ... SafetyCall medical and toxicology professionals are ...
Cached Medicine Technology:Professor Steven V. Ley Speaks at WuXi PharmaTech 2Professor Steven V. Ley Speaks at WuXi PharmaTech 3Professor Steven V. Ley Speaks at WuXi PharmaTech 4Professor Steven V. Ley Speaks at WuXi PharmaTech 5Professor Steven V. Ley Speaks at WuXi PharmaTech 6Professor Steven V. Ley Speaks at WuXi PharmaTech 7Azantis Announces New Consumer Safety Program 2
(Date:7/12/2014)... Australia (PRWEB) July 12, 2014 ... five years, despite rising competition from international and online ... annual 2.9% over the five years through 2014-15. Greater ... consumers demanding more gaming services. Rises in discretionary income ... spent more money on non-essential items such as casino ...
(Date:7/12/2014)... my mom’s stroke, she loss the use of her right side. ... his left side. Eating became a difficult task for them so ... enjoy eating again,” said an inventor, from Fayetteville, N.C. As a ... (P C H PLATE). , The PATRICIA CAROL HALL PLATE (P ... individuals who suffer from stroke, experience tremors or loss of movement. ...
(Date:7/12/2014)... OH (PRWEB) July 12, 2014 Wright & ... against DePuy Orthopedics , Inc., a subsidiary of Johnson & ... he suffers chronic pain after receiving a metal-on-metal DePuy Pinnacle ... later to remove the artificial hip implant. The DePuy hip ... Court, Northern District of Texas (Case No. 3:14-cv-2427) where ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Dubai is ... basketball legend is heading to the UAE. The ... champion will be in the UAE from 28-31 October ... in support of diabetes awareness. The event is being ... marketing and event management company based in Dubai. The ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... score of 4.1 out of 5. This above-average ... have been underpinning buyer negotiation power over the ... analyst Anna Son, “during the period, surging demand ... costs associated with new product development, have placed ...
Breaking Medicine News(10 mins):Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4
... diabetes during her pregnancy, the special form of the disease, ... risk. Moms can develop high blood pressure or preeclampsia.// Their ... To keep blood sugar under control, some women need to ... or overweight. Now that task may get easier. ...
... pharmaceutical company has launched a revolutionary drug, Bonmax (raloxifene ... Bonmax is used in the prevention and treatment of ... drug which not only safe but can also be ... occurs due to the deficiency of the oestrogen hormone ...
... some autoimmune diseases have an increased risk of asthma. ... Heidelberg in Germany and colleagues//looked at health records for ... than 60,000 youngsters.The team checked the prevalence of asthma ... type 1 diabetes and rheumatoid arthritis. ,Celiac disease ...
... patients.Retinal cell transplants can restore vision in blind rats, ... the University of Texas, have transplanted human retinal cells ... showed that the rats were then able to distinguish ... ,This is an important step on the way ...
... hailed the results of early studies into a new ... by US doctors on an anti-depression 'pacemaker' found the ... patients.// ,The pacemaker, which is implanted in ... vagus nerve in the brain. The device was originally ...
... a resolution to get fit are urged to pursue ... damage that leads to arthritis in later life.// People ... their 20s and 30s are at greater risk of ... older. The Arthritis Research Campaign says that sports injuries ...
Cached Medicine News:
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi...
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Medicine Products: